Literature DB >> 22145791

Perception of cancer and inconsistency in medical information are associated with decisional conflict: a pilot study of men with prostate cancer who undergo active surveillance.

Alvin C Goh1, Marc A Kowalkowski, Donald E Bailey, Meredith W Kazer, Sara J Knight, David M Latini.   

Abstract

UNLABELLED: Men with prostate cancer who choose active surveillance may experience anxiety and depression. Higher anxiety related to uncertainty surrounding cancer has been shown to increase the likelihood of choosing active treatment in the absence of a clinical indication. Certain characteristics, including physician influence and a neurotic personality, may also increase the risk of psychological distress. Our study identified particular areas that may affect the degree of satisfaction or uncertainty experienced by men choosing active surveillance. We showed that men with a positive outlook who perceived that they were receiving consistent medical information had improved ability to manage uncertainty and felt more in control of their decision-making. Men who were confident in their ability to manage prostate-related symptoms also had less insecurity with their decision.
OBJECTIVE: To understand the factors associated with decision-making, we conducted a telephone-based survey as part of a pilot study to develop a psychoeducational intervention for men with prostate cancer who undergo active surveillance. PATIENTS AND METHODS: From 2007 to 2008, we conducted a cross-sectional study of 34 individuals on active surveillance for prostate cancer. We examined how specific mental health, quality of life and sociodemographic characteristics relate to decision-making. Five validated decision-making scales were used as primary outcomes reflecting the amount of satisfaction, regret and conflict a participant experienced about his decision to undergo active surveillance. A multivariate regression model was developed to identify specific psychosocial factors related to the decision-making outcomes.
RESULTS: Primary analyses focused on the decisional satisfaction and conflict measures, as the decisional regret measure showed poor reliability (α < 0.70) in this sample. Four psychosocial measures showed strong associations across the decision-making subscales, including the Fife Constructed Meaning Scale (Pearson r > 0.26), Mishel Uncertainty in Illness Scale - Inconsistency (r > 0.32), Mental Health Index-5 (r > 0.33), and Lepore self-efficacy for prostate symptom management scale (r > 0.33). Individuals with higher self-efficacy for prostate cancer symptom management (P = 0.02) and higher positive meaning for cancer (P = 0.03) were less likely to express decision-making conflict as the result of uncertainty. Individuals reporting higher positive meaning for cancer (P = 0.01) and less uncertainty in illness attributed to inconsistency (P = 0.02) were less likely to exhibit decision-making conflict related to the perceived effectiveness of treatment.
CONCLUSIONS: Men choosing active surveillance represent a patient group with unique vulnerabilities that require new psychoeducational interventions to provide information and support that will maintain and improve quality of life. We describe specific characteristics that may put patients at higher risk during the decision-making process and indicate their increased need for such interventions.
© 2011 BJU INTERNATIONAL.

Entities:  

Mesh:

Year:  2011        PMID: 22145791     DOI: 10.1111/j.1464-410X.2011.10791.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  14 in total

1.  Symptom management strategies for men with early-stage prostate cancer: results from the Prostate Cancer Patient Education Program (PC PEP).

Authors:  Alok Vij; Marc A Kowalkowski; Tae Hart; Heather Honoré Goltz; David J Hoffman; Sara J Knight; Peter R Caroll; David M Latini
Journal:  J Cancer Educ       Date:  2013-12       Impact factor: 2.037

2.  What do you mean, a spot?: A qualitative analysis of patients' reactions to discussions with their physicians about pulmonary nodules.

Authors:  Renda Soylemez Wiener; Michael K Gould; Steven Woloshin; Lisa M Schwartz; Jack A Clark
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

3.  Assessment of Decisional Conflict about the Treatment of Trigger Finger, Comparing Patients and Physicians.

Authors:  Michiel G J S Hageman; Anne-Carolin Döring; Silke A Spit; Thierry G Guitton; David Ring
Journal:  Arch Bone Jt Surg       Date:  2016-10

Review 4.  The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety.

Authors:  Alexander P Glaser; Kristian Novakovic; Brian T Helfand
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

5.  Treatment regret and quality of life following radical prostatectomy.

Authors:  Chelsea G Ratcliff; Lorenzo Cohen; Curtis A Pettaway; Patricia A Parker
Journal:  Support Care Cancer       Date:  2013-08-02       Impact factor: 3.603

6.  Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review.

Authors:  Netty Kinsella; Pär Stattin; Declan Cahill; Christian Brown; Anna Bill-Axelson; Ola Bratt; Sigrid Carlsson; Mieke Van Hemelrijck
Journal:  Eur Urol       Date:  2018-03-26       Impact factor: 20.096

7.  Decisional conflict in economically disadvantaged men with newly diagnosed prostate cancer: baseline results from a shared decision-making trial.

Authors:  Alan L Kaplan; Catherine M Crespi; Josemanuel D Saucedo; Sarah E Connor; Mark S Litwin; Christopher S Saigal
Journal:  Cancer       Date:  2014-05-09       Impact factor: 6.860

8.  Five-year nationwide follow-up study of active surveillance for prostate cancer.

Authors:  Stacy Loeb; Yasin Folkvaljon; Danil V Makarov; Ola Bratt; Anna Bill-Axelson; Pär Stattin
Journal:  Eur Urol       Date:  2014-06-30       Impact factor: 20.096

9.  Prostate cancer: A simplified prostate cancer grading system.

Authors:  Eric H Kim; Gerald L Andriole
Journal:  Nat Rev Urol       Date:  2015-08-25       Impact factor: 14.432

10.  Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer.

Authors:  Kerri Beckmann; Declan Cahill; Christian Brown; Mieke Van Hemelrijck; Netty Kinsella
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.